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Protein crystallographers continually seek improved strate-
gies to obtain crystals that will diffract to high resolution. In
order to obtain high-resolution structures it is important to
have the assurance of working with compact, well-defined
proteins. This generally accepted notion presumes that
restricting the degrees of conformational motion in a
protein increases the chances that it will crystallize into
well-ordered lattices [1]. A precisely defined compact
‘folding domain’ also results in a protein with reduced ten-
dencies towards aggregation. This paper highlights how a
combination of classical biochemical methods and powerful
new mass-spectrometric techniques can provide informa-
tion about the compact folding domains of proteins, with
unprecedented accuracy and speed. Thus, armed with a
knowledge of the precise boundaries of protein-folding
domains, protein constructs can be designed that exhibit
greater propensities towards obtaining high resolution 
diffraction-quality crystals.
Limited proteolysis to elucidate structural domains
A hallmark of large, multifunctional proteins is their mod-
ularity (Fig. 1a). The constituent modules are often
described as being organized as ‘beads on a string’. The
modules represent autonomously folded polypeptide
structures, frequently referred to as domains, where a
domain is generally from 50–150 amino-acid residues in
length. Protein domains are linked together usually by
flexible, unstructured polypeptide chains.
The classical method used to identify structural domains
within multidomain proteins is limited proteolysis. Limited
proteolysis is performed under solution conditions that
maintain the native form of the protein being investigated
(unlike complete proteolysis). Proteolytic cleavage of the
target (scissile) peptide bond requires extended polypep-
tide substrates [2]. Thus, under conditions of limited prote-
olysis, proteolytic cleavage of a multiple-domain protein is
restricted to disordered regions of the protein, such as
exposed long loops and interdomain linker chains. The
resulting cleavage products have traditionally been ana-
lyzed using a combination of SDS-PAGE and N-terminal
sequencing. Mass accuracies by SDS-PAGE, however, are
notoriously poor (±5–10%) and small peptides (<5kDa)
are difficult to analyze. In addition, N-terminal sequencing
is time consuming, expensive and the identity of the 
C-terminal residue of the domain will not be known.
Mass spectrometry for protein analysis and domain
identification
The limitations of the SDS-PAGE/N-terminal sequencing
approach to domain elucidation can be overcome through
the use of mass-spectrometric (MS) analysis (see Fig. 1b).
Two powerful methods currently dominate the field of
mass-spectrometric analysis of peptides and proteins [3,4].
These are matrix-assisted laser desorption/ionization
(MALDI) [5,6] and electrospray ionization (ESI) [7] mass
spectrometry. With MALDI-MS, complex mixtures of
peptides and proteins can be mass analyzed in minutes
and with mass accuracies to within better than 0.1 %. The
utility of limited proteolysis and MALDI-MS analysis for
domain elucidation can be seen from a recent investiga-
tion of the domain organization of the E. coli RNA poly-
merase a subunit [8]. In this study, SDS-PAGE of a
number of different proteolytic digests showed that the
a subunit comprised two domains connected by a short
flexible linker. MALDI-MS was used to determine the
exact N- and C-terminal residues of the proteolytically
released domains as well as the length of the linker chain.
Figure 1
Modular proteins and limited proteolysis. (a) Hypothetical three-domain
protein. Folding domains are shaded red, blue and green. Interdomain
linkages are denoted as thin black lines. Limited proteolysis sites are
denoted by arrows. (b) Simulated SDS-PAGE and mass-spectrometric
analyses of the three proteolytically released protein domains. The two
low molecular mass domains, overlapping in the SDS-PAGE, are
resolved in the mass spectrum.
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The authors used this information in developing a model
for the role of the a subunit in transcription activation [8].
Proteolysis to study the structure of proteins
The speed and accuracy of mass-spectrometric analysis of
proteolytic digests greatly facilitates the use of proteolysis
to probe solution structures of proteins. For example, a
comprehensive study of the protein Max was recently
undertaken using limited proteolysis and mass spectrom-
etry [9]. Max is a proto-oncogenic transcription factor
[10,11] that belongs to the basic-helix-loop-helix-zipper
(b/HLH/Z) family of DNA-binding proteins [12]. The
objectives in this investigation were to proteolytically probe
the b/HLH/Z construct of Max (residues 22–113) as well as
to explore the utility of MALDI-MS for such a study. The
high-resolution X-ray crystallographic structure of the
b/HLH/Z Max–DNA complex was available for compari-
son [13]. The crystal structure indicated that Max binds to
DNA as a symmetric homodimer via its N-terminal
a-helical basic region; the HLH regions folds into a
compact, four-helix bundle; a leucine zipper extends
immediately C-terminal to the four-helix bundle; C-termi-
nal to the zipper, the protein becomes disordered. It has
been shown that in the absence of DNA the N-terminal
region forms a random coil [14].
The proteolysis study revealed several interesting aspects
of the Max protein. In the absence of DNA and at low
ionic strengths, there was little resistance throughout the
length of the 92-residue b/HLH/Z Max peptide to any of
six proteases used (Fig. 2a). The high susceptibility to pro-
teolysis correlates with a rather flexible, open structure of
the protein. In the presence of Max-specific DNA, rates of
proteolysis fell drastically, by factors of up to 100 (Fig. 2b).
The dramatic resistance to proteolytic digestion was attrib-
uted to an increase in rigidity of the protein throughout
nearly its entire length: this was correlated with Max
homodimerization and binding of the N terminus of each
monomer to cognate DNA.
The structural information on the Max–DNA complex
inferred from proteolysis correlated very well with the X-ray
crystallographic structure. Proteolysis confirmed that the
original b/HLH/Z construct of Max used in the crystalliza-
tion study (residues 22–113, determined from sequence-
homology alignments) represented a compact folding
domain of the protein. Nevertheless, proteolysis (after 1h of
digestion) revealed a second b/HLH/Z structure (residues
25–108) that was slightly more compact than the original
b/HLH/Z construct, although the 84-residue structure
yielded to additional proteolytic digestion. A gradual prote-
olytic cleavage through the leucine zipper (over a 48h
period) resulted in a 51-residue protease-resistant structure
(residues 25–75). This structure represents a b/HLH form
of the protein. Strong resistance to any further proteolysis
demonstrated the remarkable globular-like characteristics
of the four-helix bundle [13]. In retrospect, knowledge of
the more compact, protease-resistant forms of Max may
have benefited the Max–DNA crystallization study.
Precise definition of protein domains benefits high-
resolution X-ray crystallography
The domain elucidation strategies developed in the study
of Max were directly applied to a pair of transcriptional
coactivators that were undergoing crystallization trials [15].
The proteins were dTAF42 and dTAF62 (factors associ-
ated with the Drosophila TATA-box-binding protein), sub-
units that are derived from the general transcription factor
TFIID and that are required for activated transcription
[16]. In the dTAF42 and dTAF62 sequences, a portion
shares strong similarity with the histone proteins H3 and
H4, respectively. Like histones H3 and H4, dTAF42 and
dTAF62 strongly associate in solution, forming the 
heterotetrameric complex (dTAF42/dTAF62)2.
Mass spectrometry proved to be indispensable throughout
the crystallization trials [17]. The uses of mass spectrometry
included assuring correctness of expression of the recombi-
nant protein, estimating the level of protein purity, direct
mass-spectrometric analysis of protein crystals, as well as
analysis of heavy-atom derivatives that were used for phase
determination. The greatest benefit of mass spectrometry,
however, was in the design of ‘well-behaved’ protein con-
structs for crystallization. Initial constructs of dTAF42 and
dTAF62 were designed based on sequence alignment with
the two histone proteins H3 and H4. The initial TAF con-
structs, coexpressed in E. coli as dTAF42 (1–100) and
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Figure 2
The structure of b/HLH/Z Max probed by proteolysis and mass
spectrometry. The diagram depicts proteolysis of the basic-helix-loop-
helix-zipper construct of Max (residues 22–113) in the (a) absence,
and (b) presence of Max-specific DNA. Three colors code for the
relative rates of proteolysis measured by MALDI-MS: red represents
residues in which rapid proteolysis (minutes to hours) has occurred,
green is slow to moderate proteolysis (hours to days) and blue
denotes regions where no proteolysis has occurred, even after two
days of digestion. A protease-resistant folding domain became defined
only upon DNA binding (see text). The large arrow in (b) indicates the
direction of proteolysis observed in the C-terminal region.
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dTAF62 (1–91), encompassed the histone-like regions. Fol-
lowing their copurification, the constructs were measured to
be monodisperse and tetrameric by dynamic light scattering
methods. High monodispersion usually means little or no
protein aggregation, an important condition for a successful
crystallization [18]. The TAF proteins readily crystallized,
but the crystals were small and diffracted weakly, to 4–5Å.
It was believed that some of the termini of the constructs
were flexible, a situation that would impede formation of
well-ordered crystal lattices. To define more precisely the
compact folding domains, limited proteolysis digests were
carried out on the original TAF constructs and MALDI-MS
was used to accurately and rapidly map the digests. Results
of the study are given in Figure 3. Proteolysis-resistant
regions were observed for both proteins and much of the
proteolysis was restricted to the termini. Particularly strik-
ing was the complete protection of the N-terminal of
dTAF62. The proteolysis/mass-spectrometric measure-
ments provided sufficient information to allow the redesign
of constructs for crystallization. The new constructs (Fig. 3,
blue segments) were dTAF42 (11–95) and dTAF62 (1–82).
Crystallization trials of the new dTAF42/dTAF62 complex
immediately yielded large crystals that diffracted to better
than 1.4Å resolution [15]. The structure represents the first
high-resolution view of the histone fold, showing that the
tetrameric (dTAF42/dTAF62)2 complex strongly resembles
the (H3/H4)2 heterotetrameric core of the histone octamer.
A strategy to elucidate compact folding domains using
mass spectrometry
A strategy to elucidate domains using mass spectrometry
begins at the stage of designing an initial construct of 
the protein. The amino-acid sequence of the initial con-
struct must encompass the target folding domain, nor-
mally determined from sequence-homology alignments,
secondary-structure predictions or other biochemical
means. Once the protein is expressed, time-course
limited-proteolysis experiments can be performed to
probe the protein structure and to elucidate the compact
folding domain(s). The experiments should survey various
proteases, protein:protease ratios, digest times, solution
conditions, and temperatures. MALDI-MS or ESI-MS can
be used to analyze the digest products. Guidelines for
running digests and preparing samples for MALDI-MS
analysis have been offered [9,19]. Many of the commer-
cially available MALDI-MS instruments possess multiple-
sample loading capability, so a large number of digests can
be quickly analyzed. If ESI-MS is used to analyze the
digests [20], a chromatographic separation of the digests
may be necessary [21]. The recently published high-reso-
lution X-ray crystal structure of the HIV-1 Nef protein
complexed with an SH3 protein was accomplished with
the help of limited proteolysis combined with MALDI-
MS and ESI-MS [22]. Both mass-spectrometric methods
yielded similar information concerning the compact
folding domain of the Nef–SH3 complex (UA Mirza, 
personal communication).
In summary, proteolysis and mass spectrometry provides a
powerful approach for precisely defining protein folding
domains. The method yields valuable information that
facilitates the design of protein constructs with improved
probability for crystallization into well-ordered lattices.
Mass spectrometry has developed into an invaluable tool
that should be included in the arsenal of strategies used for
attaining high-resolution X-ray crystallographic structures.
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